Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-01-05Clinical Trial Update: Pre-operative Contrast Enhanced CT to Improve Delineation of the Tumorbed in Radiotherapy for Breast Cancer. [NA]
This completed clinical trial evaluated pre-operative contrast-enhanced CT to improve delineation of the tumor bed for radiotherapy in breas…
-
CLINICAL_TRIALS trial_result · 2009-12-29Clinical Trial Update: Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial of an HLA-A*2402 restricted peptide vaccine for breast cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2009-12-29Clinical Trial Update: Polyamine-free Diet to Prevent Post Surgery Hyperalgesia [Phase 2]
A Phase 2 clinical trial tested whether a polyamine-free diet can prevent postoperative hyperalgesia in patients undergoing breast cancer su…
-
CLINICAL_TRIALS trial_result · 2009-12-29Clinical Trial Update: Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of an HLA-A*0201 restricted peptide vaccine for breast cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-12-24Clinical Trial Update: Monitoring Response to Neoadjuvant Chemotherapy by the Use of Breast Proton MR Spectroscopy
A completed clinical trial investigating the use of breast proton MR spectroscopy to monitor response to neoadjuvant chemotherapy in breast …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2009-12-24Clinical Trial Update: Observation Only Study Involving Participants Enrolled in the CHAT Trial
An administrative update describing an observation-only study involving participants enrolled in the CHAT trial for breast cancer.
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients [Phase 2]
A Phase 2 trial comparing two dosing regimens of Zoladex (goserelin) for estrogen suppression in premenopausal ER-positive breast cancer pat…
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer [Phase 1]
Phase 1 study evaluating SU011248 in combination with docetaxel in patients with metastatic breast cancer has completed, with results posted…
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: Faslodex Registry: Fulvestrant in Current Clinical Practice
AstraZeneca's Faslodex Registry study evaluating fulvestrant in current clinical practice for metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone Marrow [Phase 2]
A Phase 2 trial evaluating zoledronic acid for primary breast cancer with minimal residual disease in the bone marrow was terminated. The do…
-
CLINICAL_TRIALS trial_result · 2009-12-18Clinical Trial Update: Response to Influenza Virus Vaccination in Patients Immunocompromised Due to Chemotherapy [NA]
This completed study evaluated the immune response to influenza vaccination in patients who are immunocompromised due to chemotherapy. The t…
-
CLINICAL_TRIALS research · 2009-12-18Clinical Trial Update: Women At Risk: The High Risk Breast Cancer Program
Clinical trial update on a high-risk breast cancer program for women at risk; trial status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2009-12-15Clinical Trial Update: Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer [Phase 1]
Phase 1 study assessing the safety of an oral vinorelbine and capecitabine combination in metastatic breast cancer; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-14Clinical Trial Update: GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast Cancer [Phase 2]
Phase 2 study of GW572016 (lapatinib) in patients with ErbB2-overexpressing advanced or metastatic breast cancer has completed and results h…
-
CLINICAL_TRIALS trial_result · 2009-12-08Clinical Trial Update: A Phase III Trial For Patients With Metastatic Breast Cancer [Phase 3]
A Phase III trial evaluating a therapy for metastatic breast cancer has completed and posted results in 2009.
-
CLINICAL_TRIALS trial_result · 2009-12-07Clinical Trial Update: Study of Docetaxel in Breast Cancer Patients [Phase 3]
Sanofi-sponsored Phase 3 study of docetaxel in breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-07Clinical Trial Update: Lifemel Honey to Reduce Leucopenia During Chemotherapy [Phase 2]
This is a Phase 2 clinical trial evaluating Lifemel Honey to reduce chemotherapy-induced leucopenia in breast cancer patients. The current s…
-
CLINICAL_TRIALS trial_result · 2009-12-04Clinical Trial Update: Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane [Phase 3]
A randomized Phase III trial comparing five years of exemestane to two-and-a-half to three years of tamoxifen followed by exemestane in brea…
-
CLINICAL_TRIALS trial_result · 2009-12-03Clinical Trial Update: Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast Cancer [Phase 2]
Phase 2 salvage-therapy trial in Taiwanese patients with metastatic breast cancer evaluating the combination of bevacizumab, docetaxel, and …
-
CLINICAL_TRIALS trial_result · 2009-12-03Clinical Trial Update: A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B) [Phase 2]
Phase 2 SABRE-B trial evaluating sunitinib in combination with bevacizumab and paclitaxel for previously untreated metastatic breast cancer.…
-
CLINICAL_TRIALS trial_result · 2009-12-02Clinical Trial Update: A Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer [Phase 1, Phase 2]
A Phase 1-2 trial of XIAP antisense AEG35156 with weekly paclitaxel in advanced breast cancer was terminated.
-
CLINICAL_TRIALS research · 2009-12-01Clinical Trial Update: The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers [Phase 1]
A Phase 1 clinical trial is evaluating whether oral diindolylmethane (DIM) supplementation can increase BRCA1 protein production in BRCA1 mu…
-
CLINICAL_TRIALS research · 2009-11-25Clinical Trial Update: Evaluation of Radiation Induced Toxicity to the Heart by Multi-detector Computed Tomography (MDCT)
This clinical trial update describes a study evaluating radiation-induced heart toxicity in breast cancer patients using multi-detector CT, …
-
CLINICAL_TRIALS withdrawal · 2009-11-24Clinical Trial Update: Determining Quality of Life in Breast Cancer Patient After Completing Radiation,Chemotherapy,Surgery or Combination [Phase 2]
Phase 2 clinical trial investigating quality of life in breast cancer patients after completing various treatments has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2009-11-19Clinical Trial Update: Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy [Phase 2, Phase 3]
Phase 2/3 trial update on letrozole in combination with chemotherapy for metastatic breast cancer; the study has completed.